<DOC>
	<DOCNO>NCT00268333</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , oxaliplatin , fluorouracil , leucovorin , work different way stop growth tumor cell , either kill cell stop divide . Radiation therapy use high-energy x-ray kill tumor cell . Giving one drug ( combination chemotherapy ) together radiation therapy may kill tumor cell . PURPOSE : This phase II trial study well give combination chemotherapy together radiation therapy work treat patient recurrent metastatic colorectal cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Radiation Therapy Treating Patients With Recurrent Metastatic Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine response rate patient recurrent metastatic colorectal cancer treat neoadjuvant oxaliplatin , fluorouracil , leucovorin calcium follow radiotherapy concurrent fluorouracil oxaliplatin . Secondary - Determine overall survival disease-free survival patient treat regimen . - Determine primary site recurrence time recurrence patient treat regimen . - Determine quality life patient treat regimen . OUTLINE : This nonrandomized , open-label , multicenter study . - Neoadjuvant chemotherapy : Patients receive oxaliplatin IV 2 hour leucovorin calcium IV 2 hour day 1 . Patients also receive fluorouracil IV continuously 46 hour begin day 1 . Treatment repeat every 14 day 4 course absence disease progression unacceptable toxicity . Two 5 week later , patient stable respond disease proceed chemoradiotherapy . - Chemoradiotherapy : Patients receive fluorouracil IV continuously 5 day week 5 week oxaliplatin IV 1 hour day 1 , 8 , 15 , 22 , 29 . Patients also undergo radiotherapy 5 day week 5 week begin day 1 . Quality life assess baseline , 1 week completion neoadjuvant chemotherapy , day 15 , 30 , 42 chemoradiotherapy , 1 2 month completion study treatment . After completion study treatment , patient follow periodically . PROJECTED ACCRUAL : A total 39 patient accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm adenocarcinoma colon rectum Metastatic disease isolate follow lymph node : Aortic Interaortic Celiomesenteric Retroperitoneal , include follow site : Periuretal Liver Iliac Clavicle Mediastinum Inguinal Cervical Incompletely resect disease Recurrent disease , define 1 follow criterion : Progression occur within 6 month prior oxaliplatin patient receive prior oxaliplatin Progressive disease cisplatin fluorouracil Must able encompass radiation field PATIENT CHARACTERISTICS : ECOG performance status ( PS ) 02 Karnofsky PS 60100 % Life expectancy 12 week Absolute neutrophil count ≥ 1,500/mm^3 Platelet count ≥ 100,000 /mm^3 Alkaline phosphatase ≤ 5 time normal Bilirubin ≤ 2 time normal Creatinine &lt; 2 time normal creatinine clearance ≥ 40 mL/min No peripheral neuropathy &gt; grade 1 Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No weight loss &gt; 15 % since diagnosis recurrent disease No uncontrolled heart disease No angina No symptomatic disease inferior artery No psychological , familial , sociological , geographical condition would preclude study treatment compliance PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior chemotherapy radiotherapy No concurrent corticosteroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
</DOC>